Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

Hnk20Mab Biosimilar – Anti-RSV glycoprotein F mAb – Research Grade


Proteo Genix logo
View Antibody details

Homo sapiens Biosimilar – Anti-MUC5AC mAb – Research Grade


Proteo Genix logo
View Antibody details

HRP-conjugated anti-M13 phage antibody


Proteo Genix logo
View Antibody details

Hu23B12 Biosimilar – Anti-TSLP mAb – Research Grade


Proteo Genix logo
View Antibody details

HuCC49 Biosimilar – Anti-FCGR1/ ITGB2/ TAG-72 mAb – Research Grade


Proteo Genix logo
View Antibody details

Huj591-Gsmab Biosimilar – Anti-FOLH1/ PSMA mAb – Research Grade


Proteo Genix logo
View Antibody details

Human ACE2 Monoclonal Antibody


Proteo Genix logo
View Antibody details

Human ACVR2A & ACVR2B Monoclonal Antibody


Proteo Genix logo
View Antibody details

Human ACVRL1 Monoclonal Antibody


Proteo Genix logo
View Antibody details

Human ADAMTS5 Monoclonal Antibody 12F4


Proteo Genix logo
View Antibody details